BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• /DISREGARD RELEASE: Seegene Inc./

  We are advised by Seegene Inc. that journalists and other readers should disregard the news release, Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion , issued 11-May-2021 over PR Newswire. SOURCE Seegene Inc.

  May 20, 2021

   · 

  1 min read
• Deals

  HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs

  HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs, announced the successful closing of its CHF 18 million seed round.

  May 20, 2021

   · 

  5 min read